Chinese pharmaceutical Sinovac Biotech Ltd which makes one of the vaccines against Covid 19 most in several Latin American countries initiated on Thursday the construction of its first fill and finish plant in Chile, consolidating its presence in the Latin American country that has used its Covid-19 shot the most.
Uruguay Tuesday became the fifth country to join the European Union's covid-19 certificate program. It is also South America's first.
Chilean health authorities have approved the emergency use of the Sinovac Biotech (CoronaVac) coronavirus vaccine on children aged six years or older, it was announced Monday.
Chinese laboratory Sinovac Wednesday announced it will build a plant in Chile to locally distribute 60 million yearly doses of the Coronavac vaccine against COVID-19 with which to supply other Latin American countries.
A study by Chile's Catholic University has shown that the Chinese-developed Sinovac anticoronavirus vaccine's effectiveness was down after six months and patients would then need a third dose of the immunizer.
Uruguay's Health Minister Daniel Salinas Monday announced his country had already inoculated over half its population against SARS-Cov-2 with two doses of anticoronavirus vaccines.
Brazil's President Jair Bolsonaro has once again raised doubts about the efficacy of covid-19 vaccines and defended early treatment against the disease with controversial medicines such as chloroquine.
The prestigious Butantan Institute Monday released the results of a study carried out between February and April 2021 among 27,000 people vaccinated with CoronaVac in Serrana, São Paulo, which showed a 95% decrease in deaths from covid-19, it was announced.
Despite one of the strongest vaccination campaigns worldwide and particularly in South America, Chile has reported Friday several new covid-19 infections in the past 24 hours which would indicate the pandemic is back on the upward trend.
Rio de Janeiro's iconic statue of Jesus Christ was the recipient of an advertising campaign in favour of coronavirus vaccines, which coincided with the news that Brazil would be receiving the key ingredients from China for the local production of immunizers.